Erythropoietin Injections — for Low Haemoglobin During Chemotherapy

It works gradually. According to ASCO guidance, it typically takes several weeks before haemoglobin begins to rise — not hours or days the way a transfusion works. The pace also depends on whether your iron stores are adequate. Your team will check your haemoglobin at regular blood tests and use those results to judge whether the injection is having the expected effect.

They serve different purposes. A transfusion delivers ready-made red cells immediately — used when the drop is severe or needs correcting urgently. Erythropoietin encourages your bone marrow to rebuild levels over weeks and aims to reduce how often transfusions are needed. For some patients the two are used together. Your oncologist decides which is right based on how low your haemoglobin is and how quickly it needs correcting.

It is given as a subcutaneous injection — into the fatty tissue just under the skin, similar to the way insulin is given for diabetes. Some patients receive it at the clinic; others are shown how to give it at home. Do not change how or when you give the injection without first asking your team.

All three are brand names for epoetin alfa, the same active medicine. Eprex is the originator brand; Wepox and Hemax are approved biosimilars — medicines closely similar to the originator and approved through a rigorous regulatory process. Your oncologist or hospital prescribes whichever is available through your treatment centre. The medicine works the same way regardless of the brand name on the box.

ASCO and ESMO guidance notes a real risk of blood clots, which is why erythropoietin is prescribed only when the haemoglobin drop is significant enough that the benefit outweighs the risk. Report any new leg swelling, calf pain, chest tightness, or headache to your team the same day rather than waiting for your next visit. Your team also monitors your haemoglobin to ensure it does not rise too quickly, which itself increases clot risk.

Quite possibly. Erythropoietin signals the bone marrow to make more red cells, but iron is what those cells are built from. If your iron stores are low, the injection will not produce a full response. Your team will check your iron levels through a blood test and prescribe iron tablets or an infusion if needed. Do not start iron supplements on your own — the right form and amount depend on your blood results.

Usually not. ASCO guidance recommends stopping when the chemotherapy course is complete or when haemoglobin reaches the intended level, whichever comes first. Your team will monitor your levels and tell you when to stop. Do not stop the injections on your own, and do not continue them beyond what your team advises — both decisions belong to them.

Yes, the same medicine is used in both settings. It was first developed for people whose kidneys cannot produce enough of the hormone naturally. In cancer care it is used because chemotherapy suppresses the bone marrow's ability to respond to the hormone. The brands and the method of injection are similar, but the target haemoglobin levels and guidance on when to use it differ between kidney disease and cancer care — what applied to your family member may not apply directly to your situation.